{"id":"https://openalex.org/W1997322465","doi":"https://doi.org/10.1038/sj.bjc.6605935","title":"A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients","display_name":"A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-01","ids":{"openalex":"https://openalex.org/W1997322465","doi":"https://doi.org/10.1038/sj.bjc.6605935","mag":"1997322465","pmid":"https://pubmed.ncbi.nlm.nih.gov/20924373","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2990614"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6605935","doi":"https://doi.org/10.1038/sj.bjc.6605935","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605935","pdf_url":"https://www.nature.com/articles/6605935.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997322465"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6605935.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007519821","display_name":"Willem Joost Lesterhuis","orcid":"https://orcid.org/0000-0002-2718-276X","observed_orcids":["https://orcid.org/0000-0002-2718-276X"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W J Lesterhuis","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054219763","display_name":"I. Jolanda M. de Vries","orcid":"https://orcid.org/0000-0002-8653-4040","observed_orcids":["https://orcid.org/0000-0002-8653-4040"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"I J M de Vries","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036243241","display_name":"EHJG Aarntzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E A Aarntzen","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113716183","display_name":"Annemiek J. de Boer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A de Boer","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068046073","display_name":"Nicole M. Scharenborg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"N M Scharenborg","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003310749","display_name":"Mandy W.M.M. van de Rakt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M van de Rakt","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D-J van Spronsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113935","display_name":"Canisius-Wilhelmina Ziekenhuis","ror":"https://ror.org/027vts844","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210113935"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D-J van Spronsen","raw_affiliation_strings":["Department of Internal Medicine, Canisius Wilhelmina Hospital Nijmegen, PO Box 9015, Nijmegen 6500 GS, The Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Canisius Wilhelmina Hospital Nijmegen, PO Box 9015, Nijmegen 6500 GS, The Netherlands,","institution_ids":["https://openalex.org/I4210113935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091608460","display_name":"Frank W. M. B. Preijers","orcid":"https://orcid.org/0000-0002-7394-7364","observed_orcids":["https://orcid.org/0000-0002-7394-7364"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"F W Preijers","raw_affiliation_strings":["Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands,","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052126051","display_name":"Carl Gustav Figdor","orcid":"https://orcid.org/0000-0002-2366-9212","observed_orcids":["https://orcid.org/0000-0002-2366-9212"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C G Figdor","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015323424","display_name":"Gosse J. Adema","orcid":"https://orcid.org/0000-0002-6750-1665","observed_orcids":["https://orcid.org/0000-0002-6750-1665"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"G J Adema","raw_affiliation_strings":["Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043942519","display_name":"Cornelis J.A. Punt","orcid":"https://orcid.org/0000-0003-0846-1445","observed_orcids":["https://orcid.org/0000-0003-0846-1445","https://orcid.org/0000-0003-4196-4896"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"C J A Punt","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043942519"],"corresponding_institution_ids":["https://openalex.org/I2802934949"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.6239,"has_fulltext":true,"cited_by_count":65,"citation_normalized_percentile":{"value":0.89654892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"103","issue":"9","first_page":"1415","last_page":"1421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dendritic-cell-vaccination","display_name":"dendritic cell vaccination","score":0.9860000014305115},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9110000133514404},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.8730000257492065},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7549999952316284},{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":0.8299999833106995},{"id":"https://openalex.org/keywords/keyhole-limpet-hemocyanin","display_name":"keyhole limpet hemocyanin","score":0.9449999928474426},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.7279999852180481},{"id":"https://openalex.org/keywords/b-cell-response","display_name":"B cell response","score":0.8019999861717224},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.8330000042915344},{"id":"https://openalex.org/keywords/chemotherapy-induced-immunogenicity","display_name":"chemotherapy-induced immunogenicity","score":0.6000000238418579},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.814184308052063},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6944313645362854},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6525947451591492},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6112199425697327},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.602471649646759},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5848811864852905},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5681860446929932},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5283632874488831},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.48223933577537537},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4504188895225525},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4354717433452606},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4049493074417114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27374744415283203}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006968","descriptor_name":"Hypersensitivity, Delayed","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":9,"locations":[{"id":"doi:10.1038/sj.bjc.6605935","doi":"https://doi.org/10.1038/sj.bjc.6605935","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605935","pdf_url":"https://www.nature.com/articles/6605935.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2201518","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2990614","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire/d6c0fcd9-0f9d-4dab-829a-a7e6298394a5","doi":null,"is_oa":true,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/d6c0fcd9-0f9d-4dab-829a-a7e6298394a5","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lesterhuis, K, De Vries, I J M, Aarntzen, E A, De Boer, A, Scharenborg, N M, Van De Rakt, M, Van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J & Punt, C J A 2010, 'A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients', British Journal of Cancer, vol. 103, no. 9, pp. 1415-1421. https://doi.org/10.1038/sj.bjc.6605935","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:publications/d6c0fcd9-0f9d-4dab-829a-a7e6298394a5","doi":null,"is_oa":true,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/d6c0fcd9-0f9d-4dab-829a-a7e6298394a5","pdf_url":null,"source":{"id":"https://openalex.org/S4306402523","display_name":"UWA Profiles and Research Repository (University of Western Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lesterhuis, K, De Vries, I J M, Aarntzen, E A, De Boer, A, Scharenborg, N M, Van De Rakt, M, Van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J & Punt, C J A 2010, 'A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients', British Journal of Cancer, vol. 103, no. 9, pp. 1415-1421. https://doi.org/10.1038/sj.bjc.6605935","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:20924373","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20924373","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2990614","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2990614/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/031a7097-3229-4d52-bba7-3718934d48d5","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/031a7097-3229-4d52-bba7-3718934d48d5","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lesterhuis, W J, de Vries, I J M, Aarntzen, E A, de Boer, A, Scharenborg, N M, van de Rakt, M, van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J & Punt, C J A 2010, 'A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients', British journal of cancer, vol. 103, no. 9, pp. 1415-1421. https://doi.org/10.1038/sj.bjc.6605935","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/c3e7b233-d4a5-4e80-8f81-41fcc8498692","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/a-pilot-study-on-the-immunogenicity-of-dendritic-cell-vaccination-during-adjuvant-oxaliplatincapecitabine-chemotherapy-in-colon-cancer-patients(c3e7b233-d4a5-4e80-8f81-41fcc8498692).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British journal of cancer, 103(9), 1415 - 1421. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/87604","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/87604","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6605935","doi":"https://doi.org/10.1038/sj.bjc.6605935","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6605935","pdf_url":"https://www.nature.com/articles/6605935.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1997322465.pdf","grobid_xml":"https://content.openalex.org/works/W1997322465.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1519323231","https://openalex.org/W1908804993","https://openalex.org/W1963731263","https://openalex.org/W1971717040","https://openalex.org/W1973091654","https://openalex.org/W1978767079","https://openalex.org/W1983923482","https://openalex.org/W2011882121","https://openalex.org/W2016612145","https://openalex.org/W2025482003","https://openalex.org/W2058205936","https://openalex.org/W2081195304","https://openalex.org/W2091103707","https://openalex.org/W2093424661","https://openalex.org/W2097829667","https://openalex.org/W2130153302","https://openalex.org/W2135288013","https://openalex.org/W2142052493","https://openalex.org/W2142066580","https://openalex.org/W2144486308","https://openalex.org/W2146747550","https://openalex.org/W2147621714","https://openalex.org/W2148523692","https://openalex.org/W2151246207","https://openalex.org/W2162666572","https://openalex.org/W2164603058","https://openalex.org/W2167139482","https://openalex.org/W2333928956","https://openalex.org/W3021508179"],"related_works":["https://openalex.org/W2228519701","https://openalex.org/W2317873860","https://openalex.org/W2105366969","https://openalex.org/W2122517155","https://openalex.org/W2011882121","https://openalex.org/W2206310404","https://openalex.org/W2147621714","https://openalex.org/W2558812334","https://openalex.org/W2507413548","https://openalex.org/W2898762613"],"abstract_inverted_index":{"BACKGROUND:":[0],"Dendritic":[1],"cell":[2,60],"(DC)":[3],"vaccination":[4,188],"has":[5],"been":[6],"shown":[7],"to":[8],"induce":[9],"anti-tumour":[10,187],"immune":[11,79,100],"responses":[12,139,163,171],"in":[13,45],"cancer":[14,105],"patients,":[15,135],"but":[16,62],"so":[17],"far":[18],"its":[19],"clinical":[20],"efficacy":[21],"is":[22],"limited.":[23],"Recent":[24],"evidence":[25],"supports":[26],"an":[27,46,153],"immunogenic":[28,56],"effect":[29,69,86],"of":[30,39,58,70,77,87,133,181,185],"cytotoxic":[31],"chemotherapy.":[32,191],"Pre-clinical":[33],"data":[34],"indicate":[35],"that":[36],"the":[37,55,68,74,78,85,115,167,182],"combination":[38],"chemotherapy":[40,111],"and":[41,91,95,123],"immunotherapy":[42],"may":[43],"result":[44],"enhanced":[47,154],"anti-cancer":[48],"activity.":[49],"Most":[50],"studies":[51,65],"have":[52,66],"focused":[53],"on":[54,73,93],"aspect":[57],"chemotherapy-induced":[59],"death,":[61],"only":[63],"few":[64],"investigated":[67,84],"chemotherapeutic":[71],"agents":[72],"effector":[75],"lymphocytes":[76],"system.":[80],"METHODS:":[81],"Here":[82],"we":[83,151],"treatment":[88],"with":[89,118,189],"oxaliplatin":[90,159],"capecitabine":[92],"non-specific":[94,155],"specific":[96,186],"DC":[97],"vaccine-induced":[98],"adaptive":[99],"responses.":[101],"Stage":[102],"III":[103],"colon":[104],"patients":[106],"receiving":[107],"standard":[108],"adjuvant":[109],"oxaliplatin/capecitabine":[110],"were":[112,140,172],"vaccinated":[113],"at":[114,142],"same":[116],"time":[117],"keyhole":[119],"limpet":[120],"haemocyanin":[121],"(KLH)":[122],"carcinoembryonic":[124],"antigen":[125],"(CEA)-peptide":[126],"pulsed":[127],"DCs.":[128],"RESULTS:":[129],"In":[130,149],"4":[131],"out":[132],"7":[134],"functional":[136],"CEA-specific":[137],"T-cell":[138,156,162],"found":[141],"delayed":[143],"type":[144],"hypersensitivity":[145],"(DTH)":[146],"skin":[147],"testing.":[148],"addition,":[150],"observed":[152],"reactivity":[157],"upon":[158],"administration.":[160],"KLH-specific":[161],"remained":[164],"unaffected":[165],"by":[166],"chemotherapy,":[168],"whereas":[169],"B-cell":[170],"diminished.":[173],"CONCLUSION:":[174],"The":[175],"results":[176],"strongly":[177],"support":[178],"further":[179],"testing":[180],"combined":[183],"use":[184],"oxaliplatin-based":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997322465","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
